Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral Pipeline Against SARS-CoV-2 Virus Read more
Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19 Read more
Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference Read more
Exploring the Impact of Machine Learning and Artificial Intelligence in Drug Development from Discovery to Healthcare Read more
The Transdermal and Microneedle Drug Delivery Conference 2022 is now a Virtual Event: Online Access Only Read more
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference – A Virtual Conference with Online Access Only Read more
The Pre-filled Syringes and Injectable Devices Conference 2022 is now a Virtual Event: Online Access Only Read more
SAB Biotherapeutics Announces SAB-185 Retains Neutralization Against Omicron SARS-CoV-2 Variant In Vitro Read more
Take the State of the Industry Survey and add your views to the hundreds we already have from across the industry Read more